World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials - Boers, M; Tugwell, P; Felson, D T (J Rheumatol Suppl, 1994)
, et al.